There is a simple discount patient access scheme for isatuximab. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NHS organisations can contact GB-PatientAccess ...
After considering the feedback from consultation, the appraisal committee has prepared final draft guidance (FDG) on isatuximab in combination for untreated multiple myeloma when a stem cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback